VYNE Therapeutics announces third-quarter financial results, business updates

VYNE Therapeutics has announced its third-quarter 2023 financial results and business updates, according to a company press release.
The third-quarter revenue totaled $0.1 million vs. $0.2 million for the same quarter last year. The net loss and net loss per share for the quarter was $6.6 million and $2.01, respectively, compared with $9.5 million and $2.94 for the comparable period last year.
The company also announced it has completed an $88.2 million private placement with leading health care investors. According to the press release, the net proceeds from the offering will be used to fund

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart